Value through InnovationOctober 24 2016

Value Through Innovation is Our Vision

Boehringer Ingelheim, founded in 1885 by Albert Boehringer in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. Now, more than 125 years later, the company operates globally with 146 affiliates and more than 47,000 employees. Our focus is primarily in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.

Our Company Objectives

The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped us build on our strengths and make the most of our distinctive character for more than 125 years. Value through Innovation is what drives us to continuously search for new and innovative ways to improve the lives that we touch - whether that be lives of patients and their families, our employees or our community.

Learn more about our company awards and recognition, our locations and businesses or read through our most recent annual report.

More About Our Company

  • Company Awards & Recognition

    We are proud to be recognized for our company-wide efforts to improve the lives of patients and families, employees and for our work in the community.

  • Annual Report

    In the 2014 Annual Report, Boehringer Ingelheim posted net sales of $16.96 billion dollars (13.3 billion euros), while spending 19.9% of its prescription medicine net sales on research and development.

  • Our Locations

    Boehringer Ingelheim has U.S. operations in Ridgefield, Connecticut, St. Joseph, Missouri, and Fremont, California.

"Our success depends on a diverse and talented workforce"

Paul Fonteyne

Paul Fonteyne - President and CEO, Boehringer Ingelheim USA (Country Managing Director)

Listen to Our Podcasts

Listen to Our Podcasts